Zobrazeno 1 - 10
of 18
pro vyhledávání: '"COVID-19 service provision (including audit)"'
Publikováno v:
Rheumatology (Oxford, England)
Background/Aims The 2018 NHS Long Term Plan set a target of reducing face to face (F2F) outpatient visits by a third within 5 years. The COVID-19 pandemic forced departments to implement changes to the delivery of outpatient services at unprecedented
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e535419e9d94d4c6ef4273722f345dd0
https://doi.org/10.1093/rheumatology/keab247.065
https://doi.org/10.1093/rheumatology/keab247.065
Publikováno v:
Rheumatology (Oxford, England)
Background/Aims The COVID-19 pandemic resulted in significant disruption to outpatient services, with hospital resources redirected to acute medical and critical care units. Social distancing measures meant that routine face-to-face outpatient appoin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66b3e3bac0e5cd365fdf90cf9febb39b
https://doi.org/10.1093/rheumatology/keab247.070
https://doi.org/10.1093/rheumatology/keab247.070
Autor:
Natasha Cleaton, Sabrina Raizada
Publikováno v:
Rheumatology (Oxford, England)
Background/Aims The current COVID-19 pandemic has challenged healthcare systems worldwide stimulating a transformation of NHS services to cope with increased acute demand, while aiming to minimise viral transmission. A significant proportion of rheum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ee6730b521d87608c5ae40e108d3d04
https://doi.org/10.1093/rheumatology/keab247.068
https://doi.org/10.1093/rheumatology/keab247.068
Publikováno v:
Rheumatology (Oxford, England)
Background/Aims Telemedicine has not previously been a regular part of routine rheumatology services.Our department adopted telephone clinics during the COVID-19 pandemic. We assessed patient satisfaction by conducting a feedback survey. Our aim was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65c9e896f8f00bc7f5713e0cb2f9be0b
https://doi.org/10.1093/rheumatology/keab247.063
https://doi.org/10.1093/rheumatology/keab247.063
Publikováno v:
Rheumatology (Oxford, England)
Background/Aims The COVID-19 pandemic has necessitated profound changes to the delivery of healthcare in the UK. Our aim was to analyse whether a move to virtual care is beneficial and sustainable in a rheumatology outpatient setting. Methods Data on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcc86b2d75995d94a4168ba95dd197e5
http://europepmc.org/articles/PMC8135565
http://europepmc.org/articles/PMC8135565
Publikováno v:
Rheumatology (Oxford, England)
Background/Aims The COVID-19 pandemic has resulted in a number of changes in practice in the UK, including the reduction in routine day-case attendances for intravenous rheumatology treatments. Due to redeployment and resultant staff shortages, we re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2aa8aef06e0f1a41ec06410576599b31
http://europepmc.org/articles/PMC8135397
http://europepmc.org/articles/PMC8135397
Autor:
Kehinde Sunmboye, Swetha Byravan
Publikováno v:
Rheumatology (Oxford, England)
Background/Aims Due to the COVID-19 pandemic there have been changes to NHS services to limit unnecessary patient hospital visits and comply with new social restriction rules. One of these changes has been the introduction of virtual consultations in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e60651db3a963be82b1bd2a1467a341
https://doi.org/10.1093/rheumatology/keab247.061
https://doi.org/10.1093/rheumatology/keab247.061
Publikováno v:
Rheumatology (Oxford, England)
Background/Aims The COVID-19 pandemic has had a significant impact on the management of outpatients. During the first wave of the pandemic, and in common with other departments, almost all our patient consultations happened over the phone. As the rat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87ec6bfc2a4b5fe9c0354d695c0ba6e6
http://europepmc.org/articles/PMC8135556
http://europepmc.org/articles/PMC8135556
Autor:
Kuljeet Bhamra, Adnan D’Cunha Kamath, Patrick Hanna, Hannah Irvine, Lucy M Carter, Naim Rahimi, Ankita Sahni
Publikováno v:
Rheumatology (Oxford, England)
Background/Aims Individuals on immunosuppressive therapies were among those identified by the UK Department of Health and Chief Medical Officer as clinically extremely vulnerable to COVID-19. Advice on shielding from infection was disseminated by NHS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5f349727a3116854c79edb5b2c2a2de
https://doi.org/10.1093/rheumatology/keab247.056
https://doi.org/10.1093/rheumatology/keab247.056
Autor:
Hema Chaplin, Melissa Sweeney, Emma Caton, Hsiu Yen Tung, Lewis Carpenter, S. de Souza, Sam Norton
Publikováno v:
Rheumatology (Oxford, England)
Background/Aims Inflammatory arthritis (IA) patients have been identified as being at greater risk of severe illness from COVID-19. It is likely that lockdown restrictions enforced by the UK government in response to the COVID-19 pandemic, and subseq
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85c7d3fba1dc0be1eb5914786b4cfba2
http://europepmc.org/articles/PMC8135415
http://europepmc.org/articles/PMC8135415